Shanghai Shenqi Pharmaceutical Investment Management , Ltd. Total Current Liabilities

As of the most recent data (June 2026), 600613.SS shows a total current liabilities of $500M. That compares with $480M in the prior-year period — up 4.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 600613.SS's total current liabilities is now $500M (was $480M) — a 4.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Shanghai Shenqi Pharmaceutical Investment Management , Ltd. is outperforming or lagging.

Tracking 600613.SS's total current liabilities over time shows whether Shanghai Shenqi Pharmaceutical Investment Management , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $500M That compares with $480M in the prior-year period — up 4.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Shanghai Shenqi Pharmaceutical Investment Management , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $500M) with ownership activity and broader fundamentals.